Turning Point Therapeutics is a clinical-stage structure-based drug design company for the discovery and development of precision medicines for cancer and other diseases. They focus on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating the tumor microenvironment and tumor immunity.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Turning Point Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Turning Point Therapeutics Inc market cap is $3.78B.
What is the 52-week high for Turning Point Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Turning Point Therapeutics Inc 52 week high is $82.20 as of September 06, 2025.
What is the 52-week low for Turning Point Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Turning Point Therapeutics Inc 52 week low is $23.77 as of September 06, 2025.
What is Turning Point Therapeutics Inc stock price today?
Turning Point Therapeutics Inc stock price today is $76.01.
What was Turning Point Therapeutics Inc stock price yesterday?
Turning Point Therapeutics Inc stock price yesterday was $75.49.
What is the PE ratio of Turning Point Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Turning Point Therapeutics Inc’s P/E ratio is -11.01.
What is the Price-to-Book ratio of Turning Point Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Turning Point Therapeutics Inc P/B ratio is 4.7814.
What is the 50-day moving average of Turning Point Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Turning Point Therapeutics Inc 50-day moving average is $75.02.